Form 8-K - Current report:
SEC Accession No. 0000827871-15-000025
Filing Date
2015-04-14
Accepted
2015-04-14 09:26:52
Documents
4
Period of Report
2015-04-14
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K a8-k.htm 8-K 22956
2 EXHIBIT 99.1 tevaeaglebendaacceptedforf.htm EX-99.1 47943
3 eagletevaimage1a01.jpg GRAPHIC 89612
4 tevaeagle.jpg GRAPHIC 85201
  Complete submission text file 0000827871-15-000025.txt   313163
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 15768217
SIC: 2834 Pharmaceutical Preparations